APAC Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity
- GRA4881405
- 114 Pages
- February 2022
- Healthcare
Highlighted with 30 tables and 59 figures, this 114-page report “Asia Pacific Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Country.
Based on Test, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Lipid Panel
• Infectious Disease Testing
• Liver Panel
• Complete Blood Count (CBC)
• Electrolyte Testing
• Renal Panel
• Other Tests
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Assay Kits & Reagents
• Software & Services
By Indication the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Cardiovascular
• Cancer
• Infectious Disease
• Stroke
• Chronic Lower Respiratory Diseases
• Diabetes
• Other Indications
By Patient Gender the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Male Patients
• Female Patients
By Age Group the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Age 44 and below
• Age 45-64
• Age 65 and over
By End User the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospital & Clinics Laboratory
• Diagnostic Laboratory
• Point-of-Care Testing
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines）
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Test, Product, and Indication, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
• Abbott Laboratories
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Bio-Reference Laboratories
• Bioscientia Healthcare
• Charles River Laboratories
• Danaher Corporation
• Hoffmann-La Roche AG
• Hologic Inc.
• Qiagen NV
• Siemens Healthcare
• Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Asia Pacific Market by Test 41
3.1 Market Overview by Test 41
3.2 Lipid Panel 43
3.3 Infectious Disease Testing 44
3.4 Liver Panel 45
3.5 Complete Blood Count (CBC) 46
3.6 Electrolyte Testing 47
3.7 Renal Panel 48
3.8 Other Tests 49
4 Segmentation of Asia Pacific Market by Product 50
4.1 Market Overview by Product 50
4.2 Instruments 52
4.3 Assay Kits & Reagents 53
4.4 Software & Services 54
5 Segmentation of Asia Pacific Market by Indication 55
5.1 Market Overview by Indication 55
5.2 Cardiovascular 57
5.3 Cancer 58
5.4 Infectious Disease 59
5.5 Stroke 60
5.6 Chronic Lower Respiratory Diseases 61
5.7 Diabetes 62
5.8 Other Indications 63
6 Segmentation of Asia Pacific Market by Patient Gender 64
6.1 Market Overview by Patient Gender 64
6.2 Male Patients 66
6.3 Female Patients 67
7 Segmentation of Asia Pacific Market by Age Group 68
7.1 Market Overview by Age Group 68
7.2 Age 44 and below 70
7.3 Age 45-64 71
7.4 Age 65 and over 72
8 Segmentation of Asia Pacific Market by End User 73
8.1 Market Overview by End User 73
8.2 Hospital & Clinics Laboratory 75
8.3 Diagnostic Laboratory 76
8.4 Point-of-Care Testing 77
8.5 Other End Users 78
9 Asia-Pacific Market 2021-2031 by Country 79
9.1 Overview of Asia-Pacific Market 79
9.2 Japan 82
9.3 China 85
9.4 Australia 87
9.5 India 90
9.6 South Korea 92
9.7 Rest of APAC Region 94
10 Competitive Landscape 96
10.1 Overview of Key Vendors 96
10.2 New Product Launch, Partnership, Investment, and M&A 99
10.3 Company Profiles 100
Abbott Laboratories 100
Becton, Dickinson and Company 102
BioMerieux SA 103
Bio-Rad Laboratories Inc. 104
Bio-Reference Laboratories 105
Bioscientia Healthcare 106
Charles River Laboratories 107
Danaher Corporation 108
Hoffmann-La Roche AG 109
Hologic Inc. 110
Qiagen NV 111
Siemens Healthcare 112
Thermo Fisher Scientific 113
RELATED REPORTS 114
Table 1. Snapshot of Asia Pacific Clinical Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Clinical Diagnostics Market 33
Table 5. Asia Pacific Clinical Diagnostics Market by Test, 2021-2031, $ mn 41
Table 6. Asia Pacific Clinical Diagnostics Market by Product, 2021-2031, $ mn 50
Table 7. Asia Pacific Clinical Diagnostics Market by Indication, 2021-2031, $ mn 55
Table 8. Asia Pacific Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn 64
Table 9. Asia Pacific Clinical Diagnostics Market by Age Group, 2021-2031, $ mn 68
Table 10. Asia Pacific Clinical Diagnostics Market by End User, 2021-2031, $ mn 73
Table 11. APAC Clinical Diagnostics Market by Country, 2021-2031, $ mn 80
Table 12. Japan Clinical Diagnostics Market by Test, 2021-2031, $ mn 84
Table 13. Japan Clinical Diagnostics Market by Product, 2021-2031, $ mn 84
Table 14. Japan Clinical Diagnostics Market by Indication, 2021-2031, $ mn 84
Table 15. China Clinical Diagnostics Market by Test, 2021-2031, $ mn 86
Table 16. China Clinical Diagnostics Market by Product, 2021-2031, $ mn 86
Table 17. China Clinical Diagnostics Market by Indication, 2021-2031, $ mn 86
Table 18. Australia Clinical Diagnostics Market by Test, 2021-2031, $ mn 88
Table 19. Australia Clinical Diagnostics Market by Product, 2021-2031, $ mn 88
Table 20. Australia Clinical Diagnostics Market by Indication, 2021-2031, $ mn 88
Table 21. India Clinical Diagnostics Market by Test, 2021-2031, $ mn 91
Table 22. India Clinical Diagnostics Market by Product, 2021-2031, $ mn 91
Table 23. India Clinical Diagnostics Market by Indication, 2021-2031, $ mn 91
Table 24. South Korea Clinical Diagnostics Market by Test, 2021-2031, $ mn 93
Table 25. South Korea Clinical Diagnostics Market by Product, 2021-2031, $ mn 93
Table 26. South Korea Clinical Diagnostics Market by Indication, 2021-2031, $ mn 93
Table 27. Clinical Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 95
Table 28. Abbott Laboratories: Company Snapshot 100
Table 29. Abbott Laboratories: Business Segmentation 101
Table 30. Abbott Laboratories: Product Portfolio 101
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
